Phages reconstitute NAD<sup>+</sup> to counter bacterial immunity.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39322677.
- Also identified by DOI 10.1038/s41586-024-07986-w.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Bacteria defend against phage infection through a variety of antiphage defence systems<sup>1</sup>. Many defence systems were recently shown to deplete cellular nicotinamide adenine dinucleotide (NAD<sup>+</sup>) in response to infection, by cleaving NAD<sup>+</sup> into ADP-ribose (ADPR) and nicotinamide<sup>2-7</sup>. It was demonstrated that NAD<sup>+</sup> depletion during infection deprives the phage of this essential molecule and impedes phage replication. Here we show that a substantial fraction of phages possess enzymatic pathways allowing reconstitution of NAD<sup>+</sup> from its degradation products in infected cells. We describe NAD<sup>+</sup> reconstitution pathway 1 (NARP1), a two-step pathway in which one enzyme phosphorylates ADPR to generate ADPR pyrophosphate (ADPR-PP), and the second enzyme conjugates ADPR-PP and nicotinamide to generate NAD<sup>+</sup>. Phages encoding NARP1 can overcome a diverse set of defence systems, including Thoeris, DSR1, DSR2, SIR2-HerA and SEFIR, all of which deplete NAD<sup>+</sup> as part of their defensive mechanism. Phylogenetic analyses show that NARP1 is primarily encoded on phage genomes, suggesting a phage-specific function in countering bacterial defences. A second pathway, NARP2, allows phages to overcome bacterial defences by building NAD<sup>+</sup> using metabolites different from ADPR-PP. Our findings reveal a unique immune evasion strategy in which viruses rebuild molecules depleted by defence systems, thus overcoming host immunity.
Medical subject headings
- Bacteria
- Bacteriophages
- Immune Evasion
- NAD